Bluejay Diagnostics BJDX Stock
Bluejay Diagnostics Price Chart
Bluejay Diagnostics BJDX Financial and Trading Overview
| Bluejay Diagnostics stock price | 1.81 USD |
| Previous Close | 0.21 USD |
| Open | 0.21 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 1100 |
| Day's Range | 0.2 - 0.23 USD |
| 52 Week Range | 0.19 - 1.53 USD |
| Volume | 154.78K USD |
| Avg. Volume | 505.81K USD |
| Market Cap | 4.58M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 277.2 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3 USD |
BJDX Valuation Measures
| Enterprise Value | -1935506 USD |
| Trailing P/E | N/A |
| Forward P/E | -2.24 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.402016 |
| Price/Book (mrq) | 0.5 |
| Enterprise Value/Revenue | -7.772 |
| Enterprise Value/EBITDA | 0.2 |
Trading Information
Bluejay Diagnostics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -78.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.53 USD |
| 52 Week Low | 0.19 USD |
| 50-Day Moving Average | 0.29 USD |
| 200-Day Moving Average | 0.57 USD |
BJDX Share Statistics
| Avg. Volume (3 month) | 505.81K USD |
| Avg. Daily Volume (10-Days) | 421.01K USD |
| Shares Outstanding | 20.46M |
| Float | 10.22M |
| Short Ratio | 0.11 |
| % Held by Insiders | 44.54% |
| % Held by Institutions | 1.40% |
| Shares Short | 126.79K |
| Short % of Float | 1.09% |
| Short % of Shares Outstanding | 0.61% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3986.94% |
| Gross Margin | 19.63% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -40.076% |
| Return on Equity (ttm) | -71.049% |
Income Statement
| Revenue (ttm) | 249.04K USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 48.91K USD |
| EBITDA | -9692443 USD |
| Net Income Avi to Common (ttm) | -9823388 USD |
| Diluted EPS (ttm) | -0.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.78M USD |
| Total Cash Per Share (mrq) | 0.33 USD |
| Total Debt (mrq) | 478.4K USD |
| Total Debt/Equity (mrq) | 5.22 USD |
| Current Ratio (mrq) | 6.268 |
| Book Value Per Share (mrq) | 0.448 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8797945 USD |
| Levered Free Cash Flow (ttm) | -6642405 USD |
Profile of Bluejay Diagnostics
| Country | United States |
| State | MA |
| City | Acton |
| Address | 360 Massachusetts Avenue |
| ZIP | 01720 |
| Phone | 844 327 7078 |
| Website | https://www.bluejaydx.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 16 |
Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Q&A For Bluejay Diagnostics Stock
What is a current BJDX stock price?
Bluejay Diagnostics BJDX stock price today per share is 1.81 USD.
How to purchase Bluejay Diagnostics stock?
You can buy BJDX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bluejay Diagnostics?
The stock symbol or ticker of Bluejay Diagnostics is BJDX.
Which industry does the Bluejay Diagnostics company belong to?
The Bluejay Diagnostics industry is Medical Devices.
How many shares does Bluejay Diagnostics have in circulation?
The max supply of Bluejay Diagnostics shares is 1.49M.
What is Bluejay Diagnostics Price to Earnings Ratio (PE Ratio)?
Bluejay Diagnostics PE Ratio is 0.00652958 now.
What was Bluejay Diagnostics earnings per share over the trailing 12 months (TTM)?
Bluejay Diagnostics EPS is 277.2 USD over the trailing 12 months.
Which sector does the Bluejay Diagnostics company belong to?
The Bluejay Diagnostics sector is Healthcare.
Bluejay Diagnostics BJDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
- {{ link.label }} {{link}}